Kimura I - Search Results

1

Phase II study of NK313 in malignant lymphomas: an NK313 Malignant Lymphoma Study Group trial.

Yoshida T, Ogawa M, Ota K, Yoshida Y, Wakui A, Oguro M, Ariyoshi Y, Hirano M, Kimura I, Matsuda T. Yoshida T, et al. Among authors: kimura i. Cancer Chemother Pharmacol. 1993;31(6):445-8. doi: 10.1007/BF00685033. Cancer Chemother Pharmacol. 1993. PMID: 7680966 Clinical Trial.

2

[Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)].

Ota K, Wakui A, Majima H, Niitani H, Inuyama Y, Ogawa M, Ariyoshi Y, Yoshida O, Taguchi T, Kimura I, et al. Ota K, et al. Among authors: kimura i. Gan To Kagaku Ryoho. 1992 Jun;19(6):855-61. Gan To Kagaku Ryoho. 1992. PMID: 1605663 Japanese.

3

[Early phase II study of MST-16 (sobuzoxane) on malignant lymphoma].

Tominaga N, Teshima H, Hiraoka A, Masaoka T, Ariyoshi Y, Suzuki H, Kimura I, Ohnoshi T, Hayashi K, Arima T, et al. Tominaga N, et al. Among authors: kimura i. Gan To Kagaku Ryoho. 1991 Nov;18(14):2441-6. Gan To Kagaku Ryoho. 1991. PMID: 1952963 Japanese.

4

Treatment of acute leukemia and malignant lymphoma with (2"R)-4'-O-tetrahydropyranyladriamycin.

Ohno R, Kimura K, Amaki I, Hirano M, Hoshino A, Ikeda Y, Kimura I, Kobayashi M, Konno K, Majima H, et al. Ohno R, et al. Among authors: kimura k, kimura i. Cancer Chemother Pharmacol. 1987;20(3):230-4. doi: 10.1007/BF00570491. Cancer Chemother Pharmacol. 1987. PMID: 3315282 Clinical Trial.

5

Phase I study of NKT-01.

Tamura K, Niitani H, Oguro M, Ohno R, Sanpi K, Majima H, Masaoka T, Kimura I, Inagaki J, Suzuoki Y, et al. Tamura K, et al. Among authors: kimura i. Cancer Chemother Pharmacol. 1995;36(3):189-94. doi: 10.1007/BF00685845. Cancer Chemother Pharmacol. 1995. PMID: 7781137 Clinical Trial.

6

[Early phase II clinical trial of amrubicin hydrochloride in patients with malignant lymphoma].

Masaoka T, Ogawa M, Inoue K, Sanpi K, Kuraishi Y, Toki H, Tamura K, Takagi T, Shibata A, Hirano M, Ezaki K, Shirakawa S, Matsuda T, Kimura I. Masaoka T, et al. Among authors: kimura i. Gan To Kagaku Ryoho. 2001 Nov;28(12):1857-65. Gan To Kagaku Ryoho. 2001. PMID: 11729478 Clinical Trial. Japanese.

7

[A phase I study on a weekly schedule of DWA2114R].

Niitani H, Fukuoka M, Furusawa M, Tamura M, Hasegawa K, Kurita Y, Ariyoshi Y, Matsunaga T, Kumoi T, Kimura I, et al. Niitani H, et al. Among authors: kimura i. Gan To Kagaku Ryoho. 1992 Jul;19(7):1027-32. Gan To Kagaku Ryoho. 1992. PMID: 1626938 Japanese.

8

[Phase II study of VP-16 (capsule) in malignant lymphomas. A cooperative study].

Sampi K, Ogawa M, Maekawa T, Takaku F, Kuraishi Y, Ota K, Hirano M, Hoshino A, Shirakawa S, Kimura I, et al. Sampi K, et al. Among authors: kimura i. Gan To Kagaku Ryoho. 1985 Feb;12(2):314-9. Gan To Kagaku Ryoho. 1985. PMID: 3970554 Japanese.

9

[Phase I study of a new antitumor antibiotic, neothramycin].

Kimura K, Ogawa M, Wakui A, Oguro M, Koyama Y, Saito T, Furue H, Ota K, Yamada K, Hoshino A, Nakamura T, Masaoka T, Taguchi T, Kimura I, Hattori T. Kimura K, et al. Among authors: kimura i. Gan To Kagaku Ryoho. 1982 May;9(5):924-9. Gan To Kagaku Ryoho. 1982. PMID: 7184435 Japanese.

10

[An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with hematological malignancies].

Ohno R, Yoshida Y, Oguro M, Ogawa M, Sakai Y, Furue H, Ariyoshi Y, Saito H, Masaoka T, Kimura I, et al. Ohno R, et al. Among authors: kimura i. Gan To Kagaku Ryoho. 1994 Jan;21(1):75-82. Gan To Kagaku Ryoho. 1994. PMID: 8291918 Clinical Trial. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,155 results

Search Page

Filters